Explore more publications!

Press Releases

INVESTOR ALERT: CoreWeave, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Securities Class Action Lawsuit - RGRD Law
Only 4% of Finance Teams Have Fully Automated Accounts Payable Despite Widespread Software Adoption
Dream Chasers Capital nominates Moishe Gubin - Chairman of record setting NYSE--Listed Optimum Bank to Carver Bancorp Board
Obioha Okereke Introduced as Key Member of Georgia Financial Educators Council Advisory Board
Amarin Reports Fourth Quarter and Full Year 2025 Financial Results
Kimco Realty® Management to Present at the Raymond James Institutional Investors Conference
Flywire to Attend Upcoming Investor Conferences
MLG Capital Joins iCapital Marketplace to Expand RIA Access to Alternative Investments
Intuitive Machines Advancing Satellite Communications and In-Space Data Processing Capabilities with $175 Million Strategic Investment
La Mancha Investments S. à r. l. to File Early Warning Report
Greystone Provides $22.3 Million in Fannie Mae DUS® Financing for Multifamily Property in Ogden, Utah
Immunocore reports fourth quarter and full year 2025 financial results and provides a business update
OTC Markets Group Welcomes RFA Financial Inc. to OTCQX
Altus Group Releases Q4 2025 U.S. Investment & Transactions Quarterly Report
Finrob Closes $3.9M Seed to Bring AI-Powered Research to Crypto and Financial Markets
Avista Corp. Reports 2025 Financial Results, Initiates 2026 Utility Earnings Guidance
RZOLV Technologies to Present at the Clean Energy & Renewables Virtual Investor Conference March 5th
Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Nasdaq Raises Medium‑Term Revenue Outlook and Outlines Strategy for Its Next Phase of Scalable Growth at 2026 Investor Day
Century Therapeutics to Participate in Upcoming Investor Conferences in March

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions